Kindly see information and registration link to an upcoming medical education webinar, looking at the impact of COVID-19 on TB, comparing perspectives and experiences from South Africa to that of England.
Please note: This webinar is hosted by The Union, and all content is created and paid for by Oxford Immunotec. All paid for sessions are reviewed for compliance with The Union’s mission and vision.
This webinar will address several challenges and controversies about the twin epidemics of COVID-19 and tuberculosis (TB) from both an English and a South African perspective.
Facilitated by Dr Jurgens Peters from Oxford Immunotec, expert speakers Prof Keertan Dheda and Dr Raman Verma will discuss the presentation and investigation, transmission, and subversion of TB control efforts during the pandemic, each offering their unique perspective from the UK and South African contexts.
Facilitator: Dr Jurgens Peters | Oxford Immunotec, Global Medical Advisor
Speaker one: Prof Keertan Dheda, University of Cape Town, South Africa & London School of Hygiene and Tropical Medicine, United Kingdom
Giving the South African perspective on the topic of TB and COVID-19: challenges and controversies, Professor Dheda is a hospital-based clinician, Head of the Division of Pulmonology at the University of Cape Town, and immediate past president of the South African Thoracic Society. His research work has focussed on respiratory pathogens including TB. He has been the recipient of several prestigious awards including the International Union Against Tuberculosis and Lung Disease Scientific Award and the 2018 European Union-funded EDCTP Scientific Leadership Award. He has been profiled in The Lancet and serves on several national and international academic and advisory bodies, including the editorial boards of the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He has published almost 300 papers, has a Scopus H index of 61, and is a co-inventor on 6 patents related to diagnostics and vaccines.
Speaker two: Dr Raman Verma, University Hospitals of Leicester NHS Trust; University of Leicester, United Kingdom
Giving the English perspective on the twin epidemics of TB and COVID-19: challenges and controversies, Dr Verma has been working in Respiratory Medicine for the last 10 years and working with the Leicester TB Service for the last six years. Alongside his clinical work, Dr Verma is a keen researcher, particularly interested in understanding the immune response to Mycobacterium tuberculosis exposure, diagnostics, treatment monitoring and drug trials. Dr Verma is currently part of a local COVID-19 taskforce managing in-patients and helping the Public Health response to the pandemic.